Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Food and Drug Administration Announces First CBD Public Hearing Date

Food and Drug Administration Announces First CBD Public Hearing DateCanadian Minister of Border Security and Organized Crime Reduction, Bill Blair, recently made public that the Canadian government is setting aside C$25 million for cannabis research funding. During his tenure as a Member of Parliament, Blair was one of the driving forces which led to the success of the Cannabis Act.

Blair just announced the research funding through a tweet, “[It’s] critical to ensure Canadians have the information they need about cannabis as part of our public health approach to legalization, the health impacts and potential benefits of cannabis.”

The study will be carried out at the University of Calgary. The study will be multi-faceted. One of the focus areas will involve Cannabinoid Hyperemesis Syndrome (CHS). There is little detail on the ailment. However, available data suggests it occurs as a result of long-term cannabis use intolerance.

According to the Director of Communications for Blunt Talks, “Experiencing Cannabinoid Hyperemesis Syndrome has been challenging physically and mentally. I’ve desperately been searching for more information but there’s a major lack of research on CHS. I am beyond excited to hear that Canada is going to be leading the charge with research on this controversial topic. Canada’s dedication to education is groundbreaking and I think it’s going to inspire more doctors worldwide to study the topic as well.”

Blair also mentioned that students will be developing a cannabis education program. “For many years we could tell our kids was ‘just say no,’ now we can start telling our kids, ‘think’. Just think about the science, the evidence, the impact on your life. The potential harms and risks for your decisions. And those choices need to come from sources they trust.”

Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Food and Drug Administration Announces First CBD Public Hearing Date

About Cannin: Your Marijuana Stock Experts

Cannin is your #1 trusted resource for marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest.

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com

Can we start writing exclusively about Hemp-Only companies? These include the following: Charlotte’s Web, GW Pharma, CV Sciences, Canopy Growth, Elixinol, Organigram, GrowLife, Emerald Health, Neptune, Global Hemp Group. Also, please see the attached report with additional hemp only companies with analysis. It’s from last year so the data is not current but worth a look.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Investing in Hemp Stocks